BPA Call 75F40122A00009-75F40123F19059

Award Date 4/20/23
Potential Completion Date 4/23/24
Potential Value $496K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the Food and Drug Administration (FDA) to provide program management support to the Office of the Center for Biologics Evaluation and Research (CBER) Deputy Director, primarily in coordinating the CBER Rare Disease Program and implementing the Rare Disease Endpoint Advancement (RDEA) pilot program. The contract, valued at $370,147.80, was awarded to the prime contractor Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The contract is a...
This is a federal contract award by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm, for organizational change management support for the Center for Biologics Evaluation and Research (CBER) and the Office of Regulatory Operations (ORO). The contract has a ceiling value of $1,303,361.31 and a completion date of September 29, 2024. It was awarded under the Multiple Award Schedule (MAS) contract vehicle, which allows for the provision...
This is a contract award by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The $840,379.10 contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle, with a period of performance through September 30, 2025. The contract is for organizational change management support services for the FDA's Center for Biologics Evaluation and Research (CBER) and Office of Regulatory Operations...
This is a contract award by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The contract, valued at $2,504,871.93, is a Blanket Purchase Agreement (BPA) call for program operations and implementation support. The contract has a period of performance through April 2, 2025 and was awarded on February 17, 2023. Eagle Hill Consulting has a number of existing indefinite-delivery vehicles with the FDA, including a $149 million BPA for...
The U.S. Food and Drug Administration (FDA) awarded a $1,116,980.40 contract to Eagle Hill Consulting, LLC, a woman-owned management consulting firm, to provide business process improvement and strategic planning services. The contract was awarded under the Multiple Award Schedule (MAS) contract vehicle, with a period of performance through December 4, 2024. This represents a task order under a larger $149 million Blanket Purchase Agreement (BPA) that Eagle Hill holds with the FDA for...
This federal contract award was issued by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The $76,087.58 BPA call covers the completion of strategic planning services for the FDA's Center for Biologics Evaluation and Research (CBER). The contract is under the Professional Services Schedule (PSS) and utilizes a Labor Hours pricing type. This appears to be part of a larger $149 million BPA the FDA has with Eagle Hill for strategic...
This contract award for $1,621,962.66 was made by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract. Under this task order, Eagle Hill Consulting will provide business transformation support, strategic planning, organizational assessments, and regulatory program modernization services to the FDA. The original solicitation was...
This federal contract was awarded by the Food and Drug Administration (FDA) to the prime contractor, Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The $4,723,838.31 contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) vehicle, which will provide Program Support for the FDA's Center for Biologics Evaluation and Research's (CBER) Activity Time Tracking System (CATTS) and transition to the Insight Time Reporting (ITR) system. The...
This is a $685,563.54 Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The contract is for CDER (Center for Drug Evaluation and Research) consulting support services, including strategic planning, organizational change management, program management, business process improvement, and human capital development. The BPA is part of a larger $149 million FDA BPA that covers a range of...
This is a $2,202,447.99 firm fixed-price Blanket Purchase Agreement (BPA) call award issued by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Eagle Hill Consulting, LLC, a woman-owned limited liability company and management consulting firm. The contract is for business process improvement and strategic planning services in support of the Center for Drug Evaluation and Research's Office of Pharmaceutical Quality. The work is to be performed in Silver...

This is a $496,154 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Eagle Hill Consulting, LLC, a woman-owned management consulting firm. The contract is a task order under the FDA's $149 million Blanket Purchase Agreement (BPA) for strategic planning, organizational change management, and regulatory support services. The contract will provide program management support for the FDA's Center for Biologics Evaluation and Research (CBER) Rare Disease Program. The contract has an ultimate completion date of April 23, 2024 and was awarded on April 20, 2023 with no set-aside designation.

Generated 12/5/24, 10:10 AM